z-logo
open-access-imgOpen Access
TECRL : connecting sequence to consequence for a new sudden cardiac death gene
Author(s) -
Perry Matthew D,
Vandenberg Jamie I
Publication year - 2016
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.201606967
Subject(s) - sudden cardiac death , sudden death , medicine , genetic testing , cause of death , mutation , pediatrics , gene , cardiology , genetics , disease , biology
The sudden unexpected death of a child is a devastating event. One of the first questions a family will ask is “Why did this happen?” In some cases, the answer may become obvious during a postmortem examination, but in up to 40% of cases, the postmortem is negative (Bagnall et al , [Bagnall RD, 2016]). In the last 1–2 decades, an improved understanding of the genetic basis of the primary arrhythmia syndromes, the major cause of sudden unexplained death in children with structurally normal hearts, has greatly enhanced our ability to make a postmortem diagnosis (Van Norstrand & Ackerman, [Van Norstrand DW, 2010]). Establishing an accurate genetic diagnosis can not only answer the parents' question as to why did this happen to my child, but is invaluable for cascade screening of all family members to identify other individuals harbouring the same mutation and who therefore may be at risk of sudden cardiac death. However, even after screening for all of the established genes associated with primary arrhythmia syndromes, up to two thirds of unexplained cardiac deaths will remain unsolved. Such was the case for a family of Sudanese origin with a highly malignant form of exercise‐induced arrhythmias, originally reported by Bhuiyan et al ([Bhuiyan ZA, 2007]).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here